Many recent studies have focused on the ontogeny of central opioid systems and their functional roles in development. Although data from in vivo and in vitro studies suggest that opioid peptides influence growth and differentiation, analysis of underlying mechanism in heterogeneous systems is complex. We therefore propose to use a neurochemically identifiable population of neurons, those of the noradrenergic brainstem nucleus, locus coeruleus (LC), as a model with which to examine the possible developmental role of opioid peptides. The maturation of LC and the effects of opioid receptor manipulation, will be examined in vitro in dissociated cells in culture. Morphological development will be examined in cells labelled with [3H] norepinephrine (NE) and with antibodies directed towards the principal catecholamine synthetic enzyme, tyrosine hydroxylase (TH). Indices of functional maturation, including TH mRNA expression and stimulus-evoked [3H]NE release, will also be assessed. In preliminary studies, we have found that chronic treatment of embryonic rhombencephalic cells with Beta-endorphin produces a significant enhancement of LC cell growth, as determined by [3H]NE uptake. The mechanism and pharmacology of this opioid effect will be studied in detail. The potencies of selective opioid receptor antagonists to antagonize this Beta-endorphin effect will be examined, as will the effects of other endogenous opioid peptides. Since the growth-promoting action of Beta-endorphin is diminished in defined medium, we propose to test the hypothesis that opioid effects on LC development are mediated indirectly via glia. We will also test the hypothesis, derived from in vivo data, that opioids potentiate the degenerative effect of catecholamine neurotoxins. In order to determine the cellular specificity of opioid actions on the processes of LC differentiation, the effects of opioid peptides on cultured mesencephalic dopamine neurons and rhombencephalic serotonin cells will also be examined. The use of these dissociated culture models will permit greater control of experimental variables, and analysis of cellular mechanisms of development. These studies are of both physiological and clinical interest, in that they address mechanisms underlying normal brain development and the possible influence of environmental factors on these processes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS019319-10
Application #
2263571
Study Section
Neurology B Subcommittee 2 (NEUB)
Project Start
1983-04-01
Project End
1996-06-30
Budget Start
1994-07-01
Budget End
1996-06-30
Support Year
10
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California Irvine
Department
Pharmacology
Type
Schools of Medicine
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
Winzer-Serhan, Ursula H; Chen, Yiling; Leslie, Frances M (2003) Expression of opioid peptides and receptors in striatum and substantia nigra during rat brain development. J Chem Neuroanat 26:17-36
Leslie, F M; Chen, Y; Winzer-Serhan, U H (1998) Opioid receptor and peptide mRNA expression in proliferative zones of fetal rat central nervous system. Can J Physiol Pharmacol 76:284-93
Kitchen, I; Leslie, F M; Kelly, M et al. (1995) Development of delta-opioid receptor subtypes and the regulatory role of weaning: radioligand binding, autoradiography and in situ hybridization studies. J Pharmacol Exp Ther 275:1597-607
Raymon, H K; Leslie, F M (1994) Opioid effects on [3H]norepinephrine release from dissociated embryonic locus coeruleus cell cultures. J Neurochem 62:1015-24
Smith, J A; Leslie, F M; Broide, R S et al. (1993) Long-term changes in striatal opioid systems after 6-hydroxydopamine lesion of rat substantia nigra. Neuroscience 55:935-51
Raymon, H K; Smith, T D; Leslie, F M (1992) Further pharmacological characterization of [3H]idazoxan binding sites in rat brain: evidence for predominant labeling of alpha 2-adrenergic receptors. Brain Res 582:261-7
Smith, J A; Loughlin, S E; Leslie, F M (1992) kappa-Opioid inhibition of [3H]dopamine release from rat ventral mesencephalic dissociated cell cultures. Mol Pharmacol 42:575-83
Loughlin, S E; An, A; Leslie, F M (1992) Opioid receptor changes in weaver mouse striatum. Brain Res 585:149-55
Arnsten, A F; Leslie, F M (1991) Behavioral and receptor binding analysis of the alpha 2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-yl amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an alpha 2-adrenoceptor subtype. Neuropharmacology 30:1279-89
Loughlin, S E; Kornblum, H I; Massamiri, T et al. (1991) Transient appearance of beta-endorphin immunoreactive cells within the germinal zone of neonatal rat forebrain. Int J Dev Neurosci 9:493-500

Showing the most recent 10 out of 22 publications